Device Trial Radar · NCT02766907
Optimizing the Ocular Surface Prior to Cataract Surgery
Last checked: Nov 19, 2026Latest source record: Mar 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Mar 2016
Primary completion
Jan 2017
Study completion Apr 2018
Sponsor
- Lead sponsor
- BioTissue Holdings, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 10, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective study to evaluate the efficacy of using self-retained cryopreserved amniotic membrane after debridement in treating Epithelial Base Membrane Dystrophy (EBMD) to optimize the ocular surface integrity and intraocular lens calculation before cataract surgery.
Conditions
- Corneal Dystrophy, Epithelial Basement Membrane
Interventions
cryopreserved amniotic membraneDevice
placement of cryopreserved amniotic membrane after routine debridement procedure for EBMD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Intraocular Lens CalculationTime frame: Change from Baseline to 1 month
- Change in Intraocular Lens Power CalculationTime frame: Change from Baseline to 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Virginia Eye Consultants
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.